Skip to content

Vaxcyte, Inc. PCVX Book value per share

Book value per share at other companies

Pfizer logo
PfizerPFE
$15.72-0.6%
Moderna logo
ModernaMRNA
$18.75-28.1%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$41.85+27.0%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$0.85-22.2%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$75.54+18.8%

Other financials

Income statement

See full
Operating income-$345.9M-91.3%
Net income-$320.6M-128%
EPS (diluted)-$2.30-121%

Balance sheet

See full
Cash & equivalents$262.3M-24.7%
Total debt$116.3M+33.5%
Total equity$3.0B-6.4%
Total assets$3.3B-0.9%

Cash flow

See full
Operating cash flow-$280.6M-68.8%
CapEx$2.1M-61.2%
Free cash flow-$282.7M-64.7%

Valuation

See full
Market cap$7.43B+72.0%
Enterprise value$7.28B+78.6%

Returns & leverage

See full
Return on equity-30.6%+37.9pp
Debt / equity0.0×
Current ratio7.5×-10.2×

Where this comes from

Calculated from Vaxcyte, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vaxcyte, Inc.'s book value per share?
Vaxcyte, Inc. (PCVX) reported book value per share of $21.48 in Q1 2026.
How has Vaxcyte, Inc.'s book value per share changed year-over-year?
Vaxcyte, Inc.'s book value per share decreased by 8.9% year-over-year, from $23.58 to $21.48.
What is the long-term trend for Vaxcyte, Inc.'s book value per share?
Over 5 years (2020 to 2025), Vaxcyte, Inc.'s book value per share has grown at a 23.8% compound annual growth rate (CAGR), from $6.79 to $19.73.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.